Why Is Gene Therapy Focused Senti Bio Stock Falling Today?

Senti Bio reports encouraging SENTI-202 AML trial results as the FDA grants RMAT status, with strong response rates, durable ...

Senti Bio Announces Updated SENTI-202 Clinical Data from Ongoing Phase 1 Trial in Relapsed or Refractory Acute Myeloid Leukemia Patients, Demonstrating Deep, MRD Negative ...

ASH 2025 oral presentation on SENTI-202 in 20 Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) patients (18 response evaluable) shows high ...
PharmiWeb

Satellos Receives Clearance by U.S. FDA and Global Regulators to Initiate Pediatric Phase 2 Study of SAT-3247 for Duchenne Muscular Dystrophy

Placebo-controlled Phase 2 study will evaluate SAT-3247 treatment over three months among ambulatory children with Duchenne- Study endpoints include safety and tolerability, effect on muscle force and ...

Drug resistance in pancreatic cancer: Scientists pinpoint major and minor signaling pathways that drive it

Cancer drug resistance is the devastating reason that treatments fail and cancers metastasize, spreading to distant sites ...

Like living cells, oil-in-water droplets form 'arms' in response to their environment

Oil-in-water droplets respond to chemical cues by forming arm-like extensions that resemble filopodia, which are used by ...

Simplified lab process produces potent nerve-blocking molecules found in shellfish

Chemists have long been fascinated and frustrated by saxitoxin: a molecule that causes temporary paralysis by blocking the ...
News-Medical.Net on MSN

Study uncovers how the body's bile acids bind to block C. diff's most dangerous toxin

In a major step towards a precision therapy for Clostridioides difficile (C. diff) infection, researchers at The Hospital for ...